Lundbeck, Otsuka collborate on Alzheimer's

Share this article:

Lundbeck and Otsuka are working together on a vaccine to combat Alzheimer's disease. This would be the duo's third Alzheimer's collaboration, and the agreement tethers the companies through Phase I.

This effort is an anti-beta amyloid vaccine that the companies expect would be used in the elderly. The companies said in a statement that the idea behind the treatment is that it could preserve cognitive function by preventing amyloid-beta deposits from accumulating.

The companies will decide next steps when Phase I ends. They expect the study to start next year.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.

AbbVie's files all-oral HCV drug with FDA

AbbVie's all-oral HCV treatment filed off six Phase-III trials spanning 25 countries and 2,300 patients

Rumor: Pfizer offered to buy AstraZeneca

The rumored $101 billion bid would give Pfizer a foothold in imuno-oncology and diabetes.